Injection for muscle loss in older adults
Treatments studied
Part of Bones, joints & muscles clinical trials.
This study tests an investigational injection (IN-207907) to see if it can improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will receive the injection and be monitored for safety and effectiveness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older (women must not be able to become pregnant).
- You have a formal diagnosis of sarcopenia (muscle loss with aging).
- Your weight is at least 35 kg (about 77 lbs) and your BMI is between 15 and 30.
- You are well-nourished, based on a quick nutrition questionnaire.
- You are able to walk without help and have no conditions that limit physical activity.
- You do not have serious untreated health problems like diabetes, heart disease, or severe mental illness.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called AMC6156 to see if it can help improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will also follow exercise and nutrition guidance.
This trial tests an experimental medicine called PLH-2301 to see if it can help improve muscle strength and function in people with age-related muscle loss (sarcopenia). It may be an option if you are 65 or older, have been diagnosed with sarcopenia, and can walk on your own.
This study tests whether a drug called Denosumab, which is used to treat bone loss, can also help improve muscle strength and mass in older adults who have both osteoporosis and sarcopenia. If you qualify, you would receive the drug and be monitored over time to see if it helps your bones and muscles.
This trial tests a traditional Chinese medicine ointment, applied externally, to help older adults with sarcopenia (muscle loss) improve muscle strength and physical function. Researchers want to see if it is safe and works as an add-on to usual care.
This study tests an investigational drug called Isomyosamine, which aims to reduce inflammation and prevent muscle loss after a hip or thigh fracture. It is designed for older adults who are at risk for frailty or sarcopenia after their injury.
This trial tests an injection of donor bone marrow stem cells to see if it can improve muscle strength and function in people with age-related muscle loss, called sarcopenia. It may help those who cannot do regular exercise training.
Hear when a new Sarcopenia in Elderly trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.